MEMOTEXT, CAMH and OBIO® partner to support healthcare workers’ mental health through digital engagement

May 27, 2024 (Toronto, ON)  – MEMOTEXT Corp., a leading digital platform provider for patient engagement in North America, is thrilled to announce the successful completion of an evaluation project through OBIO’s Early Adopter Health Network (EAHN™) of its MTxBeWell program with the Centre for Addiction and Mental Health (CAMH). This ground-breaking initiative represents a significant advancement in mental health support and paves the way for pre-procurement activities and reimbursement across Ontario.

With the support from EAHN™, CAMH has been able to offer the MTxBeWell program to its social workers and occupational therapists.

The MTxBeWell program is a validated, just-in-time adaptive intervention designed to engage individuals in their mental health journey. Co-created by Dr. Gillian Strudwick and Dr. Tracie Risling, this innovative SMS-based tool checks in with users and provides relevant mental health and resilience support based on individual needs. By leveraging personalized messaging, the program aims to enhance well-being and foster mental health awareness.

“Bringing accessibility-focused, real-time mental health supports to employees proactively is part of the MTxBeWell mission and we’ve been fortunate that this has shown such meaningful engagement,” said Amos Adler, CEO of MEMOTEXT.

Through this collaboration, over 160 CAMH clinical staff were provided access to the co-designed MTxBeWell program. Over a 12-week cycle, the SMS-based program delivered psychoeducation resources, curated digital mental health tools, wellness supports, mindfulness tips, and information about eligible mental health resources. By providing timely and relevant support, CAMH aimed to alleviate stress and burnout among its dedicated staff.

The majority of the clinical staff who reported one or more symptoms of burnout responded positively to and actively engaged with the program. The respondents were satisfied with the regular self-care reminders and the resources provided while being able to incorporate these activities in their workday. Overall, the program successfully achieved its goals using a simple, yet well designed implementation, leading to a positive recommendation from the users and the clinical team.

Dr. Gillian Strudwick emphasized the importance of engagement at the right time and in the right context. “We’re excited to bring this program to the employees of CAMH,” she said. “Supporting their mental health and well-being is crucial, especially given the challenges faced by healthcare workers.”

Dr. Maura Campbell, President and CEO of OBIO®, recognizes the urgency of addressing healthcare worker burnout: “In the past three years, burnout among healthcare workers has reached an all-time high,” she noted. “OBIO® is proud to support the collaboration between MEMOTEXT and CAMH to deploy a made-in-Canada solution, improving the well-being of those who tirelessly care for patients in need.”

About MEMOTEXT Corp.

MEMOTEXT Corp. is a digital health company committed to improving patient outcomes through personalized engagement. Their innovative solutions empower patients, caregivers, and healthcare providers to make informed decisions and manage health conditions effectively. For more information about the MEMOTEXT BeWell program, visit MEMOTEXT’s website.

About the Centre for Addiction and Mental Health (CAMH)

CAMH is Canada’s largest mental health and addiction teaching hospital and a world leading research centre in this field. CAMH combines clinical care, research, education, policy development and health promotion to help transform the lives of people affected by mental illness and addiction. CAMH is fully affiliated with the University of Toronto, and is a Pan American Health Organization/World Health Organization Collaborating Centre. For more information, please visit camh.ca.

About OBIO®

OBIO®, a not-for-profit, membership-based organization dedicated to advancing health technology innovation and commercialization, is prioritizing the evaluation of new technologies through their Early Adopter Health Network (EAHN™). OBIO® is engaged in strategy, programming, policy development and advocacy to further the commercialization of human health technologies, positioning Canada as a leader in the international marketplace. For more information, please visit OBIO.ca and follow OBIO® on LinkedIn and X.

Contacts:

Amos Adler, M.Sc.
CEO
MEMOTEXT Corp.
amos@memotext.com

Hayley Clark
Manager, Media Strategy, Issues Management and CEO Communications
CAMH
media@camh.ca

Doriane Rey
Senior Manager, Marketing & Communications
OBIO®
dorianerey@obio.ca